logo
logo
Sign in
robert henric 2021-09-24
img

According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, published by MarketsandMarkets™, the Diabetes Care Devices ((BRIC) Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Browse in-depth TOC on “Diabetes Care Devices Market”64 – Tables42 – Figures168 – PagesDownload PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020Based on type, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, the diabetes care devices market has been segmented into hospitals & specialty clinics and self/home healthcare.

The self/home healthcare segment is estimated to hold the largest share in 2020.

This segment is also projected to grow at the highest CAGR during the forecast period.

The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375China to hold the largest share in the market in 2020, followed by IndiaChina is projected to hold the largest share in the diabetes care devices (BRIC) market during the forecast period.

collect
1
robert henric 2020-12-22
img

According to the new market research report “Diabetes Care Devices (BRIC) Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Growth Boosting Factors:Sharp increase in diabetes in the past decadeFavorable national health strategiesGovernment-LED endorsement of the medical device industrySignificant advancements and leveraging of artificial intelligence and big dataDiabetes awareness campaigns and screening campsAsk for Free Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=375                                                                     Diabetes Care Devices MarketLeading Key Players in the Worldwide Industry:The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt.

Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).Geographical Regions Mapped in Report:China held the largest share in the diabetes care devices (BRIC) market in 2019.

This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry.

India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Market Segmentation in Detailed:Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Based on end user, the diabetes care devices (BRIC) market has been segmented into hospitals & specialty clinics and self/home healthcare.

collect
0
robert henric 2021-08-12
img

The Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″ published by MarketsandMarkets™, the diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Recent Developments;– In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.– In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.– In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.– In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375Geographically; the China held the largest share in the diabetes care devices (BRIC) market in 2019.

This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry.

India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.Key Market Players;The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt.

Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Market Segmentation in Detailed:The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices (BRIC) market in 2020Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.

collect
0
John Martin 2021-11-09
img

Diabetes care devices market is a disorder that cannot produce the insulin produced in the serum in the pancreas.

Increased blood sugar induces untreated diabetes.

Diabetes treatments are used for diabetes diagnosis in particular.

It is used primarily for the analysis for glucose levels in the body.

Diabetes care devices are small in size and also compact.North America diabetes care devices market is registering a substantial CAGR in the forecast period of 2019-2026.

This rise in the market can be attributed to the increases incidence for patients with diabetes and development of the need for a quicker, healthier and effective method of diagnosing and treating diabetes.This North America Diabetes Care Devices Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.

collect
0
robert henric 2021-07-13
img

The report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.The Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020Based on type, segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.

The self/home healthcare segment is estimated to hold the largest share in 2020.

This segment is also projected to grow at the highest CAGR during the forecast period.

The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Geographical View in-detailed:China held the largest share in the diabetes care devices (BRIC) market in 2019.

collect
0
robert henric 2020-08-07
img

The research study involved the extensive use of both primary and secondary sources.

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.How the market Growth Impact in terms of revenue?

The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Diabetes Care Devices Market, Growth Factor Analysis:Sharp increase in diabetes in the past decadeFavorable national health strategiesGovernment-LED endorsement of the medical device industryDiabetes awareness campaignsIncreasing penetration of smartphones and rising focus on digital healthSpeak to Our Research Analyst, to resolve your Queries: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=375Blood Glucose Monitoring System Estimates to Dominate the Growth of the market.

Insulin Delivery Devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Self/Home Healthcare Is Projected To Witness the Highest CAGR Growth.

collect
0
robert henric 2020-06-25
img
[168 Pages Report] The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market. Recent Developments: In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals. In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan. Browse 64 market data Tables and 42 Figures spread through 168 Pages and in-depth TOC - Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375 Market Segmentation in Depth: Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Based on end user, the diabetes care devices (BRIC) market has been segmented into hospitals & specialty clinics and self/home healthcare.
collect
0
robert henric 2021-09-24
img

According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, published by MarketsandMarkets™, the Diabetes Care Devices ((BRIC) Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Browse in-depth TOC on “Diabetes Care Devices Market”64 – Tables42 – Figures168 – PagesDownload PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020Based on type, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, the diabetes care devices market has been segmented into hospitals & specialty clinics and self/home healthcare.

The self/home healthcare segment is estimated to hold the largest share in 2020.

This segment is also projected to grow at the highest CAGR during the forecast period.

The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375China to hold the largest share in the market in 2020, followed by IndiaChina is projected to hold the largest share in the diabetes care devices (BRIC) market during the forecast period.

robert henric 2021-08-12
img

The Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″ published by MarketsandMarkets™, the diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Recent Developments;– In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.– In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.– In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.– In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375Geographically; the China held the largest share in the diabetes care devices (BRIC) market in 2019.

This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry.

India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.Key Market Players;The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt.

Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Market Segmentation in Detailed:The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices (BRIC) market in 2020Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.

robert henric 2021-07-13
img

The report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.The Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020Based on type, segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.

The self/home healthcare segment is estimated to hold the largest share in 2020.

This segment is also projected to grow at the highest CAGR during the forecast period.

The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Geographical View in-detailed:China held the largest share in the diabetes care devices (BRIC) market in 2019.

robert henric 2020-06-25
img
[168 Pages Report] The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market. Recent Developments: In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals. In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan. Browse 64 market data Tables and 42 Figures spread through 168 Pages and in-depth TOC - Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375 Market Segmentation in Depth: Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Based on end user, the diabetes care devices (BRIC) market has been segmented into hospitals & specialty clinics and self/home healthcare.
robert henric 2020-12-22
img

According to the new market research report “Diabetes Care Devices (BRIC) Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Growth Boosting Factors:Sharp increase in diabetes in the past decadeFavorable national health strategiesGovernment-LED endorsement of the medical device industrySignificant advancements and leveraging of artificial intelligence and big dataDiabetes awareness campaigns and screening campsAsk for Free Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=375                                                                     Diabetes Care Devices MarketLeading Key Players in the Worldwide Industry:The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt.

Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).Geographical Regions Mapped in Report:China held the largest share in the diabetes care devices (BRIC) market in 2019.

This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry.

India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Market Segmentation in Detailed:Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Based on end user, the diabetes care devices (BRIC) market has been segmented into hospitals & specialty clinics and self/home healthcare.

John Martin 2021-11-09
img

Diabetes care devices market is a disorder that cannot produce the insulin produced in the serum in the pancreas.

Increased blood sugar induces untreated diabetes.

Diabetes treatments are used for diabetes diagnosis in particular.

It is used primarily for the analysis for glucose levels in the body.

Diabetes care devices are small in size and also compact.North America diabetes care devices market is registering a substantial CAGR in the forecast period of 2019-2026.

This rise in the market can be attributed to the increases incidence for patients with diabetes and development of the need for a quicker, healthier and effective method of diagnosing and treating diabetes.This North America Diabetes Care Devices Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.

robert henric 2020-08-07
img

The research study involved the extensive use of both primary and secondary sources.

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.How the market Growth Impact in terms of revenue?

The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Diabetes Care Devices Market, Growth Factor Analysis:Sharp increase in diabetes in the past decadeFavorable national health strategiesGovernment-LED endorsement of the medical device industryDiabetes awareness campaignsIncreasing penetration of smartphones and rising focus on digital healthSpeak to Our Research Analyst, to resolve your Queries: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=375Blood Glucose Monitoring System Estimates to Dominate the Growth of the market.

Insulin Delivery Devices, and diabetes management mobile applications.

Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.

The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.Self/Home Healthcare Is Projected To Witness the Highest CAGR Growth.